Inventor · disambiguated record
Grant A. Krafft
Also filed as: KRAFFT GRANT · KRAFFT GRANT A
9 granted patents·21 pending applications·271 citations·filing 1996–2025
87Inventor score
Files withUNIV NORTHWESTERN10KRAFFT GRANT A4ACUMEN PHARMACEUTICALS INC3CONJUCHEM BIOTECHNOLOGIES INC2JERECIC JASNA2
Top patents by PatentIndex Score
30 records- 0193US6218506B1Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 1997·Granted Apr 17, 2001·215 cites·8 claims
- 0289US7638283B2Amyloid β protein (globular assembly and uses thereof)UNIV NORTHWESTERN·Filed 2005·Granted Dec 29, 2009·11 cites·2 claims
- 0382US7741453B2Long lasting fusion peptide inhibitors for HIV infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2002·Granted Jun 22, 2010·19 cites·73 claims
- 0469US2021386879A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 0564US8507206B2Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)LAMBERT MARY P·Filed 2005·Granted Aug 13, 2013·4 cites·1 claims
- 0662US2014322731A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2014·Application pending·0 cites
- 0761US2017209604A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2017·Application pending·0 cites
- 0859US5843634AGenetically engineered enzymes and their conjugates for diagnostic assaysABBOTT LAB·Filed 1996·Granted Dec 1, 1998·22 cites·20 claims
- 0958US2009285804A1Anti-ADDLs antibodies and uses thereofKLEIN WILLIAM L·Filed 2009·Application pending·0 cites
- 1057US2007213512A1Amyloid beta peptide analogs and assemblies thereofKRAFFT GRANT A·Filed 2007·Application pending·0 cites
- 1157US2016213794A1Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules and uses thereofUNIV NORTHWESTERN·Filed 2016·Application pending·0 cites
- 1256US2013150560A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1356US2013236466A1AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOFUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1456US2013078269A1Amyloid beta peptides, assemblies thereof, and related methodsUNIV NORTHWESTERN·Filed 2012·Application pending·0 cites
- 1555US2003068316A1Anti-ADDL antibodies and uses thereofFiled 2002·Application pending·0 cites
- 1654US2025262337A1Method for detecting soluble oligomeric amyloid betaUNIV NORTHWESTERN·Filed 2025·Application pending·0 cites
- 1754US2007048312A1Anti-ADDL antibodies and uses thereofKLEIN WILLIAM L·Filed 2006·Application pending·0 cites
- 1852US7964359B2Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearanceACUMEN PHARMACEUTICALS INC·Filed 2007·Granted Jun 21, 2011·0 cites·2 claims
- 1952US2011098309A1Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compoundsACUMEN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2052US2004115263A1Use of bupropion for treating restless legs syndromeFiled 2003·Application pending·0 cites
- 2150US9006283B2Methods of modifying amyloid β oligomers using non-peptidic compoundsKRAFFT GRANT A·Filed 2007·Granted Apr 14, 2015·0 cites·7 claims
- 2250US8962677B2Methods of restoring cognitive ability using non-peptidic compoundsKRAFFT GRANT A·Filed 2007·Granted Feb 24, 2015·0 cites·1 claims
- 2347US2008176252A1Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereofKRAFFT GRANT A·Filed 2005·Application pending·0 cites
- 2446US2013330837A1Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta)ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2545US2011166061A1Long lasting fusion peptide inhibitors for hiv infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2010·Application pending·0 cites
- 2644US2004138296A1Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's diseasePHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2737US2006178302A1Amyloid beta protein (globular assembly and uses thereof)NORTHWESTERN UNIVERSITY & THE·Filed 2005·Application pending·0 cites
- 2836US9217024B2ADDL receptor polypeptides, polynucleotides and host cells for recombinant productionJERECIC JASNA·Filed 2008·Granted Dec 22, 2015·0 cites·27 claims
- 2933US2008306074A1Compositions Comprising Addl Receptors, Related Compositions, and Related MethodsLACOR PASCALE N·Filed 2005·Application pending·0 cites
- 3029US2008014596A1ADDL Binding to Hippocampal NeuronsJERECIC JASNA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Grant A. Krafft files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →